The global cell culture market is estimated to be valued at US$ 10.89 Bn in 2023 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Cell culture involves growing cells in a controlled nutritious environment outside their natural environment. Cell culture finds wide application in areas such as biotechnology, pharmaceuticals, toxicology testing, and regenerative medicine. The growing demand for monoclonal antibodies, recombinant proteins, stem cells, and vaccine production is increasing the need for cell culture technologies.
Market key trends:
One of the key trends in the cell culture market is the increasing adoption of single-use bioreactor systems. These systems offer advantages such as reduced complexity and labor requirement for cleaning and sterilization as compared to stainless steel bioreactors. In addition, single-use bioreactors reduce the risk of product cross-contamination. The disposable nature of the system also lowers the downtime between batches as preparation and cleaning is not required. This helps improve production efficiency and lower overall capital costs.
Segment Analysis
The global Cell Culture Market is segmented into consumables and equipment. Consumables dominated the market accounting for over 65% share in 2023. Within consumables, medium dominated the segment owing to higher utilization of cell culture medium for various cell-based research activities. Equipment segment consists of bioreactors, cell culture vessels, centrifuges, biosafety cabinets, and other supporting equipment. Bioreactors segment is expected to grow at fastest pace over the forecast period due to increasing demand for continuous cell culture process for commercial production of biopharmaceuticals and advancement in microcarrier technology.
Key Takeaways
The global cell culture market is expected to witness high growth, exhibiting CAGR of 7.2% over the forecast period, due to increasing demand for cell-based research for developing biopharmaceuticals, growing stem cell research, and rising prevalence of chronic and infectious diseases.
Regional analysis North America dominated the global cell culture market in 2023 owing to presence of leading biopharmaceutical companies, rising stem cell research, and strong government support for R&D activities in the region. Asia Pacific is expected to grow at fastest pace during the forecast period due to increasing government initiatives, improving healthcare infrastructure, and growing biotechnology industry.
Key players operating in the cell culture market are Corning Incorporated, Merck KGaA, Sartorius AG, BioSpherix, Ltd., Cell Culture Company, LLC, Thermo Fisher Scientific Inc., VWR International LLC, and Lonza. Corning Incorporated holds leading position globally owing to wide product portfolio including cell culture media, bioprocess container systems, and related equipment. Merck KGaA dominates the upstream and downstream bio production market with comprehensive offering across the bioproduction workflow.
Read More : https://www.rapidwebwire.com/ai-applications-projected-to-boost-the-growth-of-cell-culture-market/
